Drug Trial Radar · NCT06726161
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
Last checked: Nov 19, 2026Latest source record: Sep 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
590
Planned (sponsor's estimate)
Start
Sep 5, 2025
Primary completion
Jun 2030
Study completion Jun 2031
Sponsor
- Lead sponsor
- RayzeBio, Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 10, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase 1/2 randomized, controlled, open-label trial of theranostic pair RYZ811 (diagnostic) and RYZ801 (therapeutic) to identify and treat subjects with GPC3+ unresectable hepatocellular carcinoma (HCC)
Conditions
- Hepatocellular Carcinoma (HCC)
Interventions
RYZ811Diagnostic test
Ga-68
RYZ801Drug
Ac-225
Primary outcomes
What the sponsor says the trial is designed to measure.
- Therapeutic - RYZ801Time frame: Rate of DLTs during the first 42 days of study treatment
- Therapeutic - RYZ801Time frame: From enrollment for up to three months or study discontinuation, whichever occurs first.
- Therapeutic - RYZ801Time frame: From enrollment to 3months after randomization or study discontinuation, whichever occurs first.
- Diagnostic - RYZ811Time frame: Baseline, pre-injection and post-injection up to 6 days post injection.
- Diagnostic - RYZ811Time frame: RYZ811 biodistribution to be assessed on the day of injection.
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Research Facility
Birmingham, Alabama · Recruiting
Research Facility
Phoenix, Arizona · Recruiting
Research Facility
Orange, California · Recruiting
Research Facility
Jacksonville, Florida · Recruiting
Research Facility
Lexington, Kentucky · Recruiting
Research Facility
Baltimore, Maryland · Recruiting
Research Facility
Rochester, Minnesota · Recruiting
Research Facility
St Louis, Missouri · Recruiting
Research Facility
Omaha, Nebraska · Recruiting
Research Facility
New York, New York · Recruiting
Research Facility
Houston, Texas · Recruiting
Research Facility
Charlottesville, Virginia · Recruiting
Research Facility
Seattle, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.